Functions of potassium channels blocked by low micromolar 4‐aminopyridine in the crayfish nervous system

4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4‐AP at such low con...

Full description

Saved in:
Bibliographic Details
Published inSynapse (New York, N.Y.) Vol. 76; no. 7-8; pp. e22234 - n/a
Main Authors Goldfeder, Nicole, McDonald, Riley, Gaston, Sarah, Harrison, Amarri, Kim, Dong‐Ho, MacIntosh, Clara, Miranda, Mauricio Moel, Odom, Emma, Nishad, Simmi, Siwik, William, Zhang, Liangzhu, Lin, Jen‐Wei
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4‐AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K+ channels blocked by low concentrations of 4‐AP. At opener motor axons, intracellular recordings show that 4‐AP could increase action potential (AP) amplitude, duration, and after‐depolarization (ADP) at 10 μM. As 4‐AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10–50 μM and 1–5 mM. The effects of 50 μM 4‐AP on the VSF were less consistent than that observed at the opener motor axons. 4‐AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4‐AP treatment only in 30% of the axon‐EPSP pairs. 4‐AP also increased firing frequencies of ∼50% of axons. In four animals, 4‐AP “awakened” the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4‐AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4‐AP‐sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4‐AP sensitivity of the two motor systems is discussed. At opener motor axons, 4‐AP at 10 μM consistently increased AP amplitude, duration and after‐depolarization. At ventral superficial flexor (VSF), 4‐AP effects were less consistent. Changes in AP amplitude, repolarizing potential, firing frequencies and EPSPs were observed in some but not all axons. This mixture of positive and negative 4‐AP effects could be observed in the same animal. We propose that there is a significant diversity in the density of highly 4‐AP‐sensitive potassium channels among motor axons of the VSF.
AbstractList 4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4‐AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K+ channels blocked by low concentrations of 4‐AP. At opener motor axons, intracellular recordings show that 4‐AP could increase action potential (AP) amplitude, duration, and after‐depolarization (ADP) at 10 μM. As 4‐AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10–50 μM and 1–5 mM. The effects of 50 μM 4‐AP on the VSF were less consistent than that observed at the opener motor axons. 4‐AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4‐AP treatment only in 30% of the axon‐EPSP pairs. 4‐AP also increased firing frequencies of ∼50% of axons. In four animals, 4‐AP “awakened” the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4‐AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4‐AP‐sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4‐AP sensitivity of the two motor systems is discussed. At opener motor axons, 4‐AP at 10 μM consistently increased AP amplitude, duration and after‐depolarization. At ventral superficial flexor (VSF), 4‐AP effects were less consistent. Changes in AP amplitude, repolarizing potential, firing frequencies and EPSPs were observed in some but not all axons. This mixture of positive and negative 4‐AP effects could be observed in the same animal. We propose that there is a significant diversity in the density of highly 4‐AP‐sensitive potassium channels among motor axons of the VSF.
4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4‐AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K + channels blocked by low concentrations of 4‐AP. At opener motor axons, intracellular recordings show that 4‐AP could increase action potential (AP) amplitude, duration, and after‐depolarization (ADP) at 10 μM. As 4‐AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10–50 μM and 1–5 mM. The effects of 50 μM 4‐AP on the VSF were less consistent than that observed at the opener motor axons. 4‐AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4‐AP treatment only in 30% of the axon‐EPSP pairs. 4‐AP also increased firing frequencies of ∼50% of axons. In four animals, 4‐AP “awakened” the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4‐AP effects summarized above was observed in the same VSF preparations in all cases ( n  = 8). We propose that there is a significant diversity in the density 4‐AP‐sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4‐AP sensitivity of the two motor systems is discussed.
4-aminopyridine (4-AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert-Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4-AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K channels blocked by low concentrations of 4-AP. At opener motor axons, intracellular recordings show that 4-AP could increase action potential (AP) amplitude, duration, and after-depolarization (ADP) at 10 μM. As 4-AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10-50 μM and 1-5 mM. The effects of 50 μM 4-AP on the VSF were less consistent than that observed at the opener motor axons. 4-AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4-AP treatment only in 30% of the axon-EPSP pairs. 4-AP also increased firing frequencies of ∼50% of axons. In four animals, 4-AP "awakened" the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4-AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4-AP-sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4-AP sensitivity of the two motor systems is discussed.
4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4‐AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K+ channels blocked by low concentrations of 4‐AP. At opener motor axons, intracellular recordings show that 4‐AP could increase action potential (AP) amplitude, duration, and after‐depolarization (ADP) at 10 μM. As 4‐AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10–50 μM and 1–5 mM. The effects of 50 μM 4‐AP on the VSF were less consistent than that observed at the opener motor axons. 4‐AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4‐AP treatment only in 30% of the axon‐EPSP pairs. 4‐AP also increased firing frequencies of ∼50% of axons. In four animals, 4‐AP “awakened” the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4‐AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4‐AP‐sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4‐AP sensitivity of the two motor systems is discussed.
4-aminopyridine (4-AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert-Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4-AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K+ channels blocked by low concentrations of 4-AP. At opener motor axons, intracellular recordings show that 4-AP could increase action potential (AP) amplitude, duration, and after-depolarization (ADP) at 10 μM. As 4-AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10-50 μM and 1-5 mM. The effects of 50 μM 4-AP on the VSF were less consistent than that observed at the opener motor axons. 4-AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4-AP treatment only in 30% of the axon-EPSP pairs. 4-AP also increased firing frequencies of ∼50% of axons. In four animals, 4-AP "awakened" the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4-AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4-AP-sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4-AP sensitivity of the two motor systems is discussed.4-aminopyridine (4-AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert-Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4-AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K+ channels blocked by low concentrations of 4-AP. At opener motor axons, intracellular recordings show that 4-AP could increase action potential (AP) amplitude, duration, and after-depolarization (ADP) at 10 μM. As 4-AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10-50 μM and 1-5 mM. The effects of 50 μM 4-AP on the VSF were less consistent than that observed at the opener motor axons. 4-AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4-AP treatment only in 30% of the axon-EPSP pairs. 4-AP also increased firing frequencies of ∼50% of axons. In four animals, 4-AP "awakened" the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4-AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4-AP-sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4-AP sensitivity of the two motor systems is discussed.
Author Nishad, Simmi
Lin, Jen‐Wei
MacIntosh, Clara
Goldfeder, Nicole
Gaston, Sarah
Harrison, Amarri
Miranda, Mauricio Moel
Odom, Emma
Kim, Dong‐Ho
Siwik, William
McDonald, Riley
Zhang, Liangzhu
Author_xml – sequence: 1
  givenname: Nicole
  surname: Goldfeder
  fullname: Goldfeder, Nicole
  organization: Boston University
– sequence: 2
  givenname: Riley
  surname: McDonald
  fullname: McDonald, Riley
  organization: Boston University
– sequence: 3
  givenname: Sarah
  surname: Gaston
  fullname: Gaston, Sarah
  organization: Boston University
– sequence: 4
  givenname: Amarri
  surname: Harrison
  fullname: Harrison, Amarri
  organization: Boston University
– sequence: 5
  givenname: Dong‐Ho
  surname: Kim
  fullname: Kim, Dong‐Ho
  organization: Boston University
– sequence: 6
  givenname: Clara
  surname: MacIntosh
  fullname: MacIntosh, Clara
  organization: Boston University
– sequence: 7
  givenname: Mauricio Moel
  surname: Miranda
  fullname: Miranda, Mauricio Moel
  organization: Boston University
– sequence: 8
  givenname: Emma
  surname: Odom
  fullname: Odom, Emma
  organization: Boston University
– sequence: 9
  givenname: Simmi
  surname: Nishad
  fullname: Nishad, Simmi
  organization: Boston University
– sequence: 10
  givenname: William
  surname: Siwik
  fullname: Siwik, William
  organization: Boston University
– sequence: 11
  givenname: Liangzhu
  surname: Zhang
  fullname: Zhang, Liangzhu
  organization: Boston University
– sequence: 12
  givenname: Jen‐Wei
  orcidid: 0000-0002-6529-0622
  surname: Lin
  fullname: Lin, Jen‐Wei
  email: jenwelin@bu.edu
  organization: Boston University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35460585$$D View this record in MEDLINE/PubMed
BookMark eNp1kb9OHDEYxK2IKByEghdAltKQYsFe_90SISBIiBRJCirL6_XqfHjtw94FbZdHyDPyJDG5o0Gk-prfjOab2QM7IQYLwCFGJxih-jTP4aSua0I_gAVGjaxq0vAdsEBSiopSwXfBXs4rhBDBiH4Cu4RRjphkC7C6nIIZXQwZxh6u46hzdtMAzVKHYH2GrY_m3nawnaGPT3BwJsUhep0gff79Rw8uxPWcXOeChS7AcWmhSXruXV7CYNNjnDLMcx7t8Bl87LXP9mB798Gvy4uf59-qm-9X1-dnN5UhjNCKIk6R1aJjnTAGWW5wo7mhmJpW0E4LbWyHey5Q15ueENmWD2l5uGENQ0KSfXC88V2n-DDZPKrBZWO918GWNKrmjNYNl4wX9MsbdBWnFEq6QgmJaVNLVKijLTW1g-3UOrlBp1m9tliA0w1Qusk52V4ZN-qXVseknVcYqZedVNlJ_dupKL6-Ubyavsdu3Z-ct_P_QfXj7naj-AsPuKN3
CitedBy_id crossref_primary_10_1002_syn_22304
Cites_doi 10.1016/s0361‐9230(00)00335‐x
10.1016/j.neuron.2011.06.024
10.1242/jeb.43.2.211
10.1016/s0166‐2236(00)01892‐0
10.1113/jphysiol.2010.191973
10.1523/JNEUROSCI.5291‐14.2015
10.1085/jgp.98.6.1161
10.1523/JNEUROSCI.4206‐13.2014
10.1113/jphysiol.2008.153734
10.1007/bf00612428
10.1242/jeb.010868
10.1016/j.jbc.2021.100302
10.1111/j.1469‐7793.1998.183bo.x
10.1038/43119
10.1523/JNEUROSCI.1703‐17.2017
10.1152/jn.1978.41.1.85
10.1152/jn.00176.2006
10.1016/j.msard.2013.05.003
10.1152/jn.00857.2011
10.1113/jphysiol.1983.sp014942
10.3892/ol.2016.4123
10.1242/jeb.43.2.229
10.1016/j.neulet.2016.01.061
10.1111/j.1460‐9568.2004.03730.x
10.1113/jphysiol.2014.276493
10.1523/JNEUROSCI.3212‐17.2018
10.1073/pnas.0702041104
10.1016/j.bpj.2021.01.013
10.1152/jn.00092.2005
10.1016/S0006‐3495(90)82484‐X
ContentType Journal Article
Copyright 2022 Wiley Periodicals LLC.
Copyright_xml – notice: 2022 Wiley Periodicals LLC.
DBID AAYXX
CITATION
NPM
7QP
7TK
K9.
7X8
DOI 10.1002/syn.22234
DatabaseName CrossRef
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1098-2396
EndPage n/a
ExternalDocumentID 35460585
10_1002_syn_22234
SYN22234
Genre article
Journal Article
GrantInformation_xml – fundername: BU UROP (Undergraduate Research Opportunities Program)
– fundername: BU Teaching Laboratory
  funderid: BI/NE445
– fundername: BU Teaching Laboratory
  grantid: BI/NE445
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABIVO
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
C45
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GAKWD
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WUP
WXSBR
WYISQ
XG1
XV2
YNT
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AETEA
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7QP
7TK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
ID FETCH-LOGICAL-c3534-40640ea7d5d7cc0e6c19a6c414cb74da7aced1f670dfcf338b447439695950783
IEDL.DBID DR2
ISSN 0887-4476
1098-2396
IngestDate Fri Jul 11 02:13:52 EDT 2025
Sat Jul 19 13:10:56 EDT 2025
Wed Feb 19 02:26:31 EST 2025
Thu Apr 24 23:01:45 EDT 2025
Tue Jul 01 01:20:12 EDT 2025
Wed Jan 22 16:23:13 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7-8
Keywords 4-aminopyridine
neuromuscular junction
crayfish
motor axon
potassium channel
synaptic transmission
action potential
Language English
License 2022 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3534-40640ea7d5d7cc0e6c19a6c414cb74da7aced1f670dfcf338b447439695950783
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6529-0622
PMID 35460585
PQID 2678149280
PQPubID 1046379
PageCount 11
ParticipantIDs proquest_miscellaneous_2654296856
proquest_journals_2678149280
pubmed_primary_35460585
crossref_citationtrail_10_1002_syn_22234
crossref_primary_10_1002_syn_22234
wiley_primary_10_1002_syn_22234_SYN22234
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2022
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: June 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Synapse (New York, N.Y.)
PublicationTitleAlternate Synapse
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 35
2007; 104
2004; 20
2006; 96
1990; 58
1991; 98
2010; 588
2021; 120
1988; 163
2008; 586
2001; 24
2014; 592
2012; 107
2016; 11
1983; 227
1965b; 43
1983; 344
2014; 3
2017; 37
2011; 71
1978; 41
2000; 53
1997; 387
2016; 617
1998; 509
1965a; 43
2021; 296
2008; 211
2014; 34
2014; 12
2018; 38
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
Thomsen R. H. (e_1_2_8_31_1) 1983; 227
e_1_2_8_32_1
e_1_2_8_11_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
Inam Z. S. (e_1_2_8_10_1) 2014; 12
References_xml – volume: 211
  start-page: 2193
  issue: 14
  year: 2008
  end-page: 2195
  article-title: Parallel ‘phasic’ and ‘tonic’ motor systems of the crayfish abdomen
  publication-title: Journal of Experimental Biology
– volume: 24
  start-page: 517
  issue: 9
  year: 2001
  end-page: 526
  article-title: Kv3 channels: Voltage‐gated K+ channels designed for high‐frequency repetitive firing
  publication-title: Trends in Neuroscience (Tins)
– volume: 104
  start-page: 11453
  issue: 27
  year: 2007
  end-page: 11458
  article-title: Selective control of cortical axonal spikes by a slowly inactivating K+ current
  publication-title: PNAS
– volume: 12
  start-page: A140
  issue: 2
  year: 2014
  end-page: 149
  article-title: Application of a spike sorting procedure to analyze recordings in the crayfish ventral superficial flexor preparation: A high resolution approach to the study of neuromodulators on axons and synapses
  publication-title: Journal of Undergraduate Neuroscience Education
– volume: 344
  start-page: 327
  year: 1983
  end-page: 333
  article-title: Axon conduction failure under in vivo conditions in crayfish
  publication-title: Journal of Physiology
– volume: 588
  start-page: 3187
  issue: Pt 17
  year: 2010
  end-page: 3200
  article-title: Going native: Voltage‐gated potassium channels controlling neuronal excitability
  publication-title: Journal of Physiology
– volume: 227
  start-page: 260
  issue: 1
  year: 1983
  end-page: 265
  article-title: Effects of 4‐aminopyridine and 3,4‐diaminopyridine on transmitter release at the neuromuscular junction
  publication-title: Journal of Pharmacology and Experimental Therapeutics
– volume: 163
  start-page: 187
  issue: 2
  year: 1988
  end-page: 199
  article-title: Interactions between the tonic and cyclic postural motor programs in the crayfish abdomen
  publication-title: Journal of Comparative Physiology A
– volume: 98
  start-page: 1161
  issue: 6
  year: 1991
  end-page: 1179
  article-title: Calcium‐activated potassium conductance in presynaptic terminals at the crayfish neuromuscular junction
  publication-title: Journal of General Physiology
– volume: 96
  start-page: 1203
  issue: 3
  year: 2006
  end-page: 1214
  article-title: Kv1.1‐containing channels are critical for temporal precision during spike initiation
  publication-title: Journal of Neurophysiology
– volume: 38
  start-page: 3729
  issue: 15
  year: 2018
  end-page: 3740
  article-title: Regulation of nociceptive glutamatergic signaling by presynaptic Kv3.4 channels in the rat spinal dorsal horn
  publication-title: Journal of Neuroscience
– volume: 43
  start-page: 211
  issue: 2
  year: 1965a
  end-page: 227
  article-title: Reflex control of abdominal flexor muscles in the crayfish: I. The twitch system
  publication-title: Journal of Experimental Biology
– volume: 35
  start-page: 16404
  issue: 50
  year: 2015
  end-page: 16417
  article-title: Differential regulation of action potential shape and burst‐frequency firing by BK and Kv2 channels in substantia nigra dopaminergic neurons
  publication-title: Journal of Neuroscience
– volume: 41
  start-page: 85
  issue: 1
  year: 1978
  end-page: 96
  article-title: Synaptic connectivity in a crayfish neuromuscular system. II. Nerve‐muscle matching and nerve branching patterns
  publication-title: Journal of Neurophysiology
– volume: 11
  start-page: 1933
  issue: 3
  year: 2016
  end-page: 1935
  article-title: Successful treatment of Lambert–Eaton myasthenic syndrome in a small cell lung cancer patient using 3,4‐diaminopyridine: A case report
  publication-title: Oncology Letters
– volume: 387
  start-page: 869
  issue: 6636
  year: 1997
  end-page: 875
  article-title: K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons
  publication-title: Nature
– volume: 71
  start-page: 671
  issue: 4
  year: 2011
  end-page: 682
  article-title: First node of Ranvier facilitates high‐frequency burst encoding
  publication-title: Neuron
– volume: 58
  start-page: 1377
  issue: 6
  year: 1990
  end-page: 1388
  article-title: Computation of action potential propagation and presynaptic bouton activation in terminal arborizations of different geometries
  publication-title: Biophysical Journal
– volume: 96
  start-page: 1887
  issue: 4
  year: 2006
  end-page: 1901
  article-title: Two opposing roles of 4‐AP‐sensitive K+ current in initiation and invasion of spikes in rat mesencephalic trigeminal neurons
  publication-title: Journal of Neurophysiology
– volume: 120
  start-page: 756
  issue: 5
  year: 2021
  end-page: 763
  article-title: Na(+) and K(+) channels: History and structure
  publication-title: Biophysical Journal
– volume: 34
  start-page: 3719
  issue: 10
  year: 2014
  end-page: 3732
  article-title: Heteromeric Kv7.2/7.3 channels differentially regulate action potential initiation and conduction in neocortical myelinated axons
  publication-title: Journal of Neuroscience
– volume: 20
  start-page: 3313
  issue: 12
  year: 2004
  end-page: 3321
  article-title: Kv3 voltage‐gated potassium channels regulate neurotransmitter release from mouse motor nerve terminals
  publication-title: European Journal of Neuroscience
– volume: 53
  start-page: 203
  issue: 2
  year: 2000
  end-page: 209
  article-title: Differential effects of K(+) channel blockers on frequency‐dependent action potential broadening in supraoptic neurons
  publication-title: Brain Research Bulletin
– volume: 37
  start-page: 9705
  issue: 40
  year: 2017
  end-page: 9714
  article-title: Action potential broadening in capsaicin‐sensitive DRG neurons from frequency‐dependent reduction of Kv3 current
  publication-title: Journal of Neuroscience
– volume: 107
  start-page: 2692
  issue: 10
  year: 2012
  end-page: 2702
  article-title: Spatial variation in membrane excitability modulated by 4‐AP‐sensitive K+ channels in the axons of the crayfish neuromuscular junction
  publication-title: Journal of Neurophysiology
– volume: 3
  start-page: 107
  issue: 1
  year: 2014
  end-page: 109
  article-title: Positive neurologic phenomena with initiation of dalfampridine for multiple sclerosis
  publication-title: Multiple Sclerosis and Related Disorders
– volume: 586
  start-page: 3493
  issue: 14
  year: 2008
  end-page: 3509
  article-title: Initial segment Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential firing in medial nucleus of the trapezoid body neurons
  publication-title: Journal of Physiology
– volume: 617
  start-page: 32
  year: 2016
  end-page: 38
  article-title: Effects of Deltamethrin on crayfish motor axon activity and neuromuscular transmission
  publication-title: Neuroscience Letters
– volume: 509
  start-page: 183
  issue: Pt 1
  year: 1998
  end-page: 194
  article-title: Contribution of the Kv3.1 potassium channel to high‐frequency firing in mouse auditory neurones
  publication-title: Journal of Physiology
– volume: 296
  year: 2021
  article-title: A high‐affinity, partial antagonist effect of 3,4‐diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs
  publication-title: Journal of Biological Chemistry
– volume: 592
  start-page: 3687
  issue: 16
  year: 2014
  end-page: 3696
  article-title: Complete reversal of Lambert–Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist
  publication-title: Journal of Physiology
– volume: 43
  start-page: 229
  issue: 2
  year: 1965b
  end-page: 246
  article-title: Reflex control of abdominal flexor muscles in the crayfish: II. The tonic system
  publication-title: Journal of Experimental Biology
– ident: e_1_2_8_7_1
  doi: 10.1016/s0361‐9230(00)00335‐x
– ident: e_1_2_8_16_1
  doi: 10.1016/j.neuron.2011.06.024
– ident: e_1_2_8_13_1
  doi: 10.1242/jeb.43.2.211
– ident: e_1_2_8_24_1
  doi: 10.1016/s0166‐2236(00)01892‐0
– ident: e_1_2_8_11_1
  doi: 10.1113/jphysiol.2010.191973
– ident: e_1_2_8_15_1
  doi: 10.1523/JNEUROSCI.5291‐14.2015
– ident: e_1_2_8_27_1
  doi: 10.1085/jgp.98.6.1161
– ident: e_1_2_8_4_1
  doi: 10.1523/JNEUROSCI.4206‐13.2014
– ident: e_1_2_8_12_1
  doi: 10.1113/jphysiol.2008.153734
– ident: e_1_2_8_21_1
  doi: 10.1007/bf00612428
– ident: e_1_2_8_3_1
  doi: 10.1242/jeb.010868
– volume: 227
  start-page: 260
  issue: 1
  year: 1983
  ident: e_1_2_8_31_1
  article-title: Effects of 4‐aminopyridine and 3,4‐diaminopyridine on transmitter release at the neuromuscular junction
  publication-title: Journal of Pharmacology and Experimental Therapeutics
– ident: e_1_2_8_23_1
  doi: 10.1016/j.jbc.2021.100302
– ident: e_1_2_8_33_1
  doi: 10.1111/j.1469‐7793.1998.183bo.x
– ident: e_1_2_8_8_1
  doi: 10.1038/43119
– ident: e_1_2_8_18_1
  doi: 10.1523/JNEUROSCI.1703‐17.2017
– ident: e_1_2_8_32_1
  doi: 10.1152/jn.1978.41.1.85
– ident: e_1_2_8_25_1
  doi: 10.1152/jn.00176.2006
– volume: 12
  start-page: A140
  issue: 2
  year: 2014
  ident: e_1_2_8_10_1
  article-title: Application of a spike sorting procedure to analyze recordings in the crayfish ventral superficial flexor preparation: A high resolution approach to the study of neuromodulators on axons and synapses
  publication-title: Journal of Undergraduate Neuroscience Education
– ident: e_1_2_8_30_1
  doi: 10.1016/j.msard.2013.05.003
– ident: e_1_2_8_17_1
  doi: 10.1152/jn.00857.2011
– ident: e_1_2_8_28_1
  doi: 10.1113/jphysiol.1983.sp014942
– ident: e_1_2_8_9_1
  doi: 10.3892/ol.2016.4123
– ident: e_1_2_8_14_1
  doi: 10.1242/jeb.43.2.229
– ident: e_1_2_8_20_1
  doi: 10.1016/j.neulet.2016.01.061
– ident: e_1_2_8_5_1
  doi: 10.1111/j.1460‐9568.2004.03730.x
– ident: e_1_2_8_29_1
  doi: 10.1113/jphysiol.2014.276493
– ident: e_1_2_8_22_1
  doi: 10.1523/JNEUROSCI.3212‐17.2018
– ident: e_1_2_8_26_1
  doi: 10.1073/pnas.0702041104
– ident: e_1_2_8_2_1
  doi: 10.1016/j.bpj.2021.01.013
– ident: e_1_2_8_6_1
  doi: 10.1152/jn.00092.2005
– ident: e_1_2_8_19_1
  doi: 10.1016/S0006‐3495(90)82484‐X
SSID ssj0003104
Score 2.35552
Snippet 4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration...
4-aminopyridine (4-AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert-Eaton disease. The concentration...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e22234
SubjectTerms 4‐aminopyridine
Action potential
Axons
crayfish
Depolarization
Excitatory postsynaptic potentials
motor axon
Motor neurons
Motor systems
Multiple sclerosis
Nervous system
neuromuscular junction
Patients
Potassium
potassium channel
Potassium channels (voltage-gated)
synaptic transmission
Title Functions of potassium channels blocked by low micromolar 4‐aminopyridine in the crayfish nervous system
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsyn.22234
https://www.ncbi.nlm.nih.gov/pubmed/35460585
https://www.proquest.com/docview/2678149280
https://www.proquest.com/docview/2654296856
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7LPvnibb2MrhJFxJfOtplcGnxaxGER3Ad1YQWh5Ird3UmH6QxSn_wJ_kZ_iSfptMt6AfGt0JSkOefkfCc55wtCz5RUAEIlyYpS6YyWvsikIDyzBbGOWK8kj4XCb4_50Ql9c8pOd9DLoRam54cYN9yiZaT1Ohq40u3BJWlo24VpdG6RCzTmakVA9O6SOgpgCx1YPikVfGAVysnB-OVVX_QbwLyKV5PDmd9An4ah9nkm59PNWk_N119YHP_zX26i61sgig97zbmFdly4jfYOAwThiw4_xyk1NO2576GzOXi_pKC48XjZrAFx15sFjlXD0HWLNbjEc2ex7vBF8wUv-iw_CJox_fHtu1rUoVl2qxr8pMN1wAA6sVmpztftZxxgtWo2Le45pe-gk_nrD6-Osu0lDZmZsRmF-JPT3ClhmRXG5I6bQipuaEGNFtQqoYyzhecit954CIg1SANQEJdMsniGeBfthia4-wgDVpSWiUJ756nNqeKyVCJSGHpA1VZN0ItBXJXZMpjHizQuqp57mVQwj1Waxwl6OjZd9rQdf2q0P8i82lpuWxEeScAkKfMJejK-BpuLBykqOJgQaBNv-eIl4xN0r9eVsZcZSyfNDAabJP737qv3H4_Tw4N_b_oQXSOx_iJtA-2j3fVq4x4BKlrrx0n9fwLFtgrQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcoALr_LYUsAghLhkm2QdO5a4VMBqgXYP0ErlgCLHD5G2m6w2u0LhxE_gN_JLGDubVOUhIW6R4siOx-P5Zuz5BuCpFBJBqIiDKJV5QFMbBYLHLNBRrE2srRTMJQofTNnkiL49To434EWXC9PyQ_QBN6cZfr92Cu4C0rvnrKF1Uw6ddaOX4LKr6O2Y81-9PyePQuBCO55PSjnreIXCeLf_9KI1-g1iXkSs3uSMr8OnbrDtTZPT4WqZD9XXX3gc__dvbsC1NRYle-3iuQkbprwFW3sl-uGzhjwj_naoD7tvwckYDaBfo6SyZF4tEXQXqxlxicPYd01ytIqnRpO8IWfVFzJrL_qh30zoj2_f5awoq3mzKNBUGlKUBHEnUQvZ2KL-TErcsKpVTVpa6dtwNH59-HISrOs0BGqUjCi6oIyGRnKdaK5UaJiKhGSKRlTlnGrJpTI6soyH2iqLPnGO4kAgxEQiEneMeAc2y6o094AgXBQ64VFujaU6pJKJVHLHYmgRWGs5gOedvDK1JjF3tTTOspZ-Oc5wHjM_jwN40jedt8wdf2q00wk9WytvncXM8YCJOA0H8Lh_jWrnzlJkaXBCsI0r9MXShA3gbrtY-l5GiT9sTnCwXuR_7z778HHqH7b_vekjuDI5PNjP9t9M392Hq7FLx_BRoR3YXC5W5gGCpGX-0OvCT1zvDuw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwEB2VVkK8cCuXhQIGIcRLtonXcWL1qaJdldsKAZWKVClyfBGh3WS12RUKT3xCv5EvYexsUpWLhHiLlInseDyeM7bnDMBTKSSCUEGDKJV5wFIbBSKhPNAR1YZqKwV3icJvJ_zgkL06io_WYKfLhWn5IfoNN2cZfr12Bj7TdvucNLRuyqFzbuwSbDAeCle3Ye_9OXcU4hbW0XwylvCOViik2_2nF53RbwjzImD1Hmd8DY67vrYXTU6Gy0U-VN9-oXH8z5-5DldXSJTstlPnBqyZ8iZs7pYYhU8b8oz4u6F-030TvozR_fkZSipLZtUCIXexnBKXNoxN1yRHn3hiNMkbclp9JdP2mh9GzYT9-H4mp0VZzZp5gY7SkKIkiDqJmsvGFvVnUuJyVS1r0pJK34LD8f7HFwfBqkpDoEbxiGEAylloZKJjnSgVGq4iIbliEVN5wrRMpDI6sjwJtVUWI-IctYEwiItYxO4Q8Tasl1Vp7gJBsCh0nES5NZbpkEkuUpk4DkOLsFrLATzv1JWpFYW5q6RxmrXkyzTDccz8OA7gSS86a3k7_iS01ek8W5lunVHuWMAETcMBPO5fo9G5kxRZGhwQlHFlvnga8wHcaedK38oo9kfNMXbWa_zvzWcfPk38w71_F30El9_tjbM3Lyev78MV6nIx_JbQFqwv5kvzABHSIn_oLeEnME4Nmw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functions+of+potassium+channels+blocked+by+low+micromolar+4%E2%80%90aminopyridine+in+the+crayfish+nervous+system&rft.jtitle=Synapse+%28New+York%2C+N.Y.%29&rft.au=Goldfeder%2C+Nicole&rft.au=McDonald%2C+Riley&rft.au=Gaston%2C+Sarah&rft.au=Harrison%2C+Amarri&rft.date=2022-06-01&rft.issn=0887-4476&rft.eissn=1098-2396&rft.volume=76&rft.issue=7-8&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fsyn.22234&rft.externalDBID=10.1002%252Fsyn.22234&rft.externalDocID=SYN22234
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-4476&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-4476&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-4476&client=summon